跳至主要内容
临床试验/EUCTR2018-003106-29-FR
EUCTR2018-003106-29-FR进行中(未招募)1 期

Feasibility and efficacy of a new ovarian stimulation regimen with RANDom start, use of corifollitropin alpha and progestin protocol for Oocyte donorS - RANDOS

CHI Créteil0 个研究点目标入组 110 人开始时间: 2018年9月25日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Donor of oocytes having spontaneous and regular menstrual cycles, and having taken no hormonal treatment (in particular contraceptive) during the cycle preceding the donation.
  • - Patient with normal ovarian reserve with antral follicle count> 8,
  • - BMI between 18 and 32
  • - Regular natural menstrual cycles, and absence of hormonal treatment during the cycle preceding the donation cycle
  • - Major patient
  • - Affiliation to social security
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 110
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Stage 3-4 endometriosis
  • - ovarian cyst> 30 mm,
  • - Polycystic ovary syndrome
  • - Patient under tutorship or curatorship

研究者

发起方
CHI Créteil

相似试验

Ovarian stimulation protocol with ultra flexible and... | 临床试验